Abstract
This article presents results of using proton therapy after operation of patient with brain meningioma. After operation brain meningiomas is known to not rarely recur due to certain localization and growth of tumor into main cerebral vessels, nerves and other main brain structures. This creates certain difficulties in operative access and surgical intervention, i.e. tumor resection. Proton therapy sharply reduces complications and improves the quality of life of patients.
Highlights
Surgical removal is believed by Erzurum et al (1970) to be a classic treatment for meningiomas. Perevodchikova (2007) noted that if the tumor was completely removed, and obtained histology confirmed its benignity, so the possibility of recurrence will be very low
As Mattos Primenta (1981) noted, proton therapy is an effective treatment for brain meningiomas
We investigated 10 patients with brain meningiomas and their recurrences who had been hospitalized and treated in the Republican Scientific Center of Neurosurgery (RSCN). 5 (50%) of them were primarily admitted and operated patients, whereas 3 (30%) patients were reoperated for recurrent brain meningiomas. 2 (20%) patients with recurrent meningiomas had not repeated surgery
Summary
Surgical removal is believed by Erzurum et al (1970) to be a classic treatment for meningiomas. Perevodchikova (2007) noted that if the tumor was completely removed, and obtained histology confirmed its benignity, so the possibility of recurrence will be very low. The purpose of our study was to improve clinical outcomes of surgical treatment of patients with brain meningiomas with subsequent use of proton therapy to prevent their recurrence. After conducting Xray therapy, patients with meningiomas and their recurrences noted significant improvement in quality of life, such symptoms as headache, nausea, vomiting, and diplopia were regressed, and control CT and MRI studies revealed a positive trend.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: European Medical, Health and Pharmaceutical Journal
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
